Serdar Dursun, Timothy G. Dinan, Chris Bushe, and Jogin Thakore

Challenges in advancing mental and physical health of patients with serious mental illness
J Psychopharmacol 2005 19: 3-5. [PDF] [References]  

Richard I. G. Holt

Obesity - an epidemic of the twenty-first century: an update for psychiatrists
J Psychopharmacol 2005 19: 6-15. [Abstract] [PDF] [References]  

Peter Haddad

Weight change with atypical antipsychotics in the treatment of schizophrenia
J Psychopharmacol 2005 19: 16-27. [Abstract] [PDF] [References]  

Chris Bushe, Peter Haddad, Robert Peveler, and John Pendlebury

The role of lifestyle interventions and weight management in schizophrenia
J Psychopharmacol 2005 19: 28-35. [Abstract] [PDF] [References]  

Sheila Tighe and Timothy Dinan

An overview of the central control of weight regulation and the effect of antipsychotic medication
J Psychopharmacol 2005 19: 36-46. [Abstract] [PDF] [References]  

Stephen C. L. Gough and Michael C. O’Donovan

Clustering of metabolic comorbidity in schizophrenia: a genetic contribution?
J Psychopharmacol 2005 19: 47-55. [Abstract] [PDF] [References]  

Richard I. G. Holt, Chris Bushe, and Leslie Citrome

Diabetes and schizophrenia 2005: are we any closer to understanding the link?
J Psychopharmacol 2005 19: 56-65. [Abstract] [PDF] [References]  

Ian S. Young

Lipids for Psychiatrists - an overview
J Psychopharmacol 2005 19: 66-75. [Abstract] [PDF] [References]  

Chris Bushe and Carol Paton

The potential impact of antipsychotics on lipids in schizophrenia: is there enough evidence to confirm a link?
J Psychopharmacol 2005 19: 76-83. [Abstract] [PDF] [References]  

Leslie Citrome

Metabolic Syndrome and Cardiovascular Disease
J Psychopharmacol 2005 19: 84-93. [Abstract] [PDF] [References]  

Richard Morriss and Faizal Amir Mohammed

Metabolism, lifestyle and bipolar affective disorder
J Psychopharmacol 2005 19: 94-101. [Abstract] [PDF] [References]  

Leslie Citrome and David Yeomans

Do guidelines for severe mental illness promote physical health and well-being?
J Psychopharmacol 2005 19: 102-109. [Abstract] [PDF] [References]  

Haya Ascher-Svanum, Michael D. Stensland, Bruce J. Kinon, and Gary D. Tollefson

Weight gain as a prognostic indicator of therapeutic improvement during acute treatment of schizophrenia with placebo or active antipsychotic
J Psychopharmacol 2005 19: 110-117. [Abstract] [PDF] [References]  

Metabolic and lifestyle issues and severe mental illness - new connections to well-being?
J Psychopharmacol 2005 19: 118-122. [PDF]  

To see an article, click its [PDF] link. To add articles to your marked citations, check the boxes to the left of the titles you want, and click the 'Add to Marked Citations' button. To see one abstract at a time, click its [Abstract] link.